Editas Medicine (EDIT) Preferred Dividend Payments (2015 - 2016)
Editas Medicine (EDIT) posted quarterly Preferred Dividend Payments of $47000.0 for Q1 2016, down 50.53% year-over-year from $95000.0 in Q2 2015, and down 52.53% quarter-over-quarter from $99000.0 in Q4 2015.
Editas Medicine (EDIT) Preferred Dividend Payments (2015 - 2016) Analysis & Trends
Editas Medicine (EDIT) has reported Preferred Dividend Payments for 2 consecutive years, with $47000.0 the latest figure, recorded in Q1 2016.
- In Q1 2016, Preferred Dividend Payments fell 50.53% year-over-year to $47000.0; the TTM figure through Dec 2016 stood at $47000.0 (down 88.07% YoY), while the FY2016 annual figure was $47000.0, down 88.07% from the prior year.
- Preferred Dividend Payments slipped to $47000.0 in Q1 2016 per EDIT's latest filing, from $99000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $104000.0 in Q3 2015 and bottomed at $47000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 47,000.00 |
| Dec 31, 2015 | 99,000.00 |
| Sep 30, 2015 | 104,000.00 |
| Jun 30, 2015 | 96,000.00 |
| Mar 31, 2015 | 95,000.00 |